Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation

Delgado-Eckert, Edgar and James, Anna and Meier-Girard, Delphine and Kupczyk, Maciej and Andersson, Lars I. and Bossios, Apostolos and Mikus, Maria and Junya, Ono and Kenji, Izuhara and Middelveld, Roelinde and Dahlén, Barbro and Gaga, Mina and Siafakas, Nikos M. and Papi, Alberto and Beghe, Bianca and Joos, Guy and Rabe, Klaus F. and Sterk, Peter J. and Bel, Elisabeth H. and Johnston, Sebastian L. and Chanez, Pascal and Gjomarkaj, Mark and Howarth, Peter H. and Niżankowska-Mogilnicka, Ewa and Dahlén, Sven-Erik and Frey, Urs. (2021) Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation. The Journal of Allergy & Clinical Immunology, 148 (2). pp. 407-419.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/82081/

Downloads: Statistics Overview


In all chronic airway diseases, the dynamics of airway function are influenced by underlying airway inflammation and bronchial hyperresponsiveness along with limitations in reversibility, due to airway and lung remodeling as well as mucous plugging. The relative contribution of each component translates into specific clinical patterns of symptoms, quality of life, exacerbation risk, and treatment success.; We aimed to evaluate whether subgrouping of patients with obstructive airway diseases according to patterns of lung function fluctuation allows identification of specific phenotypes with distinct clinical characteristics.; We applied the novel method of fluctuation-based clustering (FBC) to the twice-daily FEV; 1; measurements recorded over a one-year period in a mixed group of 134 adults with mild-to-moderate asthma, severe asthma, or COPD from the European BIOAIR cohort.; Independent of clinical diagnosis, FBC divided patients into 4 fluctuation-based clusters with progressively increasing lung functional alterations that corresponded with patterns of increasing clinical severity, risk of exacerbation and lower quality of life. Clusters of patients with airway disease were identified with significantly elevated biomarkers relating to remodeling (osteonectin) and cellular senescence (plasminogen activator inhibitor-1), accompanied by a loss of airway reversibility, pulmonary hyperinflation and loss of diffusion capacity. The 4 clusters generated were stable over time and revealed no differences in markers of type 2 inflammation (blood eosinophils and periostin).; FBC-based phenotyping provides another level of information, complementary to clinical diagnosis, and unrelated to eosinophilic inflammation, that could identify patients who may benefit from specific treatment strategies or closer monitoring.
Faculties and Departments:03 Faculty of Medicine > Bereich Kinder- und Jugendheilkunde (Klinik) > Kinder- und Jugendheilkunde (UKBB) > Pädiatrie (Frey)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Kinder- und Jugendheilkunde (Klinik) > Kinder- und Jugendheilkunde (UKBB) > Pädiatrie (Frey)
UniBasel Contributors:Frey, Urs Peter
Item Type:Article, refereed
Article Subtype:Research Article
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:03 Mar 2022 09:41
Deposited On:31 Aug 2021 12:18

Repository Staff Only: item control page